Presbyopia to impact more than 2 billion people worldwide by 2020, Alcon forecasts

Article

 

Fort Worth, TX-Eyecare professionals (ECPs) can expect to see a spike in the increase in the number of patients experiencing vision issues due to presbyopia, cautioned Alcon in a report issued recently.

Presbyopia affects nearly 1.7 billion people worldwide today, and that number is expected to soar to 2.1 billion by 2020. In the U.S., this population is expected to grow from nearly 111 million to approximately 123 million by 2020, representing an increase of more than 36% of the population within the next 7 years, Alcon said. Therefore, ECPs must be prepared to educate patients about the condition, the need for treatment to correct presbyopia, and what vision correction options are available.

“Conveying that there is no need to compromise vision acuity, comfort, convenience or even appearance is an important first step in empathizing with patients, and helping them understand what vision correction options are available,” said Roy Kline, OD, who practices in Glen Falls, NY.

“Patients rely on us to recommend a solution that corrects their vision issue,” said Victoria Dzurinko, OD, FAAO, of Downington, PA. “It is important that we explain to each presbyopic patient that our ultimate goal when recommending a vision correction option is to balance their visual needs from distance to near.”ODT

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
Neda Shamie, MD, speaks on cataract and refractive surgery at CIME 2025.
Dr Selina McGee shares thoughts on pharmacological presbyopia correction at Controversies in Modern Eye Care 2025
Paul Hammond, OD, FAAO, presents a poster at ARVO 2025 on the creation of a conversion factor between 2 OCT devices to monitor glaucoma progression
What to know about legislative moves that have been made through May this year.
CIME 25: Dilsher Dhoot, MD, FASRS, is excited about emerging retinal therapies.
Robert Maloney, MD, MA, at the 2025 Controversies in Modern Eye Care meeting
Dr Jacob Lang at the 2025 Controversies in Modern Eye Care meeting
Steven Ferrucci, OD, FAAO, at Controversies in Modern Eyecare 2025
© 2025 MJH Life Sciences

All rights reserved.